Nexalin Gets US Patent for Brain Stimulation Tech...
Category : Approval/Launch 17 April 2025Nexalin Technology, Inc., the leader in Deep Intracranial Frequency Stimulation (DIF) of the brain,...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Bristol Myers’ Camzyos Phase 3 Trial Fails to Meet...
Category : Clinical Trial Update 17 April 2025Bristol Myers Squibb announced the phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the...
XellSmart's iPSC Cell Therapies for Parkinson’s &...
Category : Clinical Trial Update 17 April 2025In January 2025, the U.S. Food and Drug Administration (FDA) officially approved the Investigational...
Galderma Launches Sculptra in China to Boost Aesth...
Category : Approval/Launch 16 April 2025Swiss firm Galderma has announced the launch of Sculptra, the first proven regenerative biostimulato...
Sanofi Advances Respiratory Pipeline with Asthma D...
Category : Clinical Trial Update 16 April 2025Sanofi shared new progress from its mid- to late-stage respiratory pipeline, including preliminary p...
Latest Newsletter Post
-
XellSmart's iPSC Cell Therapies for..
17 April 2025
-
Bristol Myers’ Camzyos Phase 3 Tria..
17 April 2025
-
Nexalin Gets US Patent for Brain St..
17 April 2025
-
Boehringer, Cue Biopharma Partner f..
16 April 2025
-
Sanofi Advances Respiratory Pipelin..
16 April 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com